Ramipril 10 mg Capsule in Healthy Subjects Under Fasting Conditions
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-01-27
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 40
- Registration Number
- NCT00829452
- Locations
- 🇨🇦
Anapharm Inc., Sainte-Foy, Quebec, Canada
Ropinirole 0.25 mg Tablets Under Fasting Conditions
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-01-27
- Last Posted Date
- 2009-09-11
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 44
- Registration Number
- NCT00829504
- Locations
- 🇺🇸
Novum Pharmaceutical Research Services, Houston, Texas, United States
Medroxyprogesterone Acetate Injection 150 mg/1 mL in Postmenopausal Women
- First Posted Date
- 2009-01-27
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 124
- Registration Number
- NCT00830414
- Locations
- 🇩🇪
AAI Deutschland GmbH & Co. KG, Neu-Ulm, Germany
Risperidone 1 mg Tablets Dosed in Healthy Subjects Under Fed Conditions
- First Posted Date
- 2009-01-27
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 24
- Registration Number
- NCT00829894
- Locations
- 🇨🇦
Anapharm Inc., Sainte-Foy, Quebec, Canada
Doxycycline Monohydrate 25 mg (5mL) Oral Suspension Under Fasting Conditions
- First Posted Date
- 2009-01-27
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 30
- Registration Number
- NCT00829764
- Locations
- 🇺🇸
CEDRA Clinical Research, San Antonio, Texas, United States
Ramipril 10 mg Capsule in Healthy Subjects Under Fasting Conditions
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-01-23
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 40
- Registration Number
- NCT00828321
- Locations
- 🇨🇦
Anapharm Inc., Sainte-Foy, Quebec, Canada
© Copyright 2024. All Rights Reserved by MedPath